News

New physician experience for the Convergent Procedure in the treatment of persistent atrial fibrillation (AF) was presented during a podium talk at the Northeast Cardiothoracic Surgical Society...

Topera, Abbott, FIRMap, rotors, rotor mapping

Abbott has entered into an agreement to purchase Topera Inc., a private, venture-backed medical device company focused on developing electrophysiology technologies to improve the diagnosis and...

St. Jude Medical Inc. today announced U.S. Food and Drug Administration (FDA) approval of its TactiCath Quartz irrigated ablation catheter, which gives physicians a real-time, objective measure of...

The electrophysiology service of the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care announces participation in a new Transatlantic Network of Excellence as part of a...

October 15, 2014 — AtriCure, Inc. today announced enrollment in the ABLATE Post Approval Study (PAS) is complete.

October 13, 2014 — After reviewing updated data and analysis for the Boston Scientific Watchman left atrial appendage (LAA) closure device, the U.S. Food and Drug Administration (FDA) Circulatory...

alivecore, alivercor, smartphone ECG, AF, Afrib, atrial fibrillation

September 29, 2014 — AliveCor announced the launch of the latest version of the AliveECG app, which provides patients with free real-time atrial fibrillation (AF) detection in electrocardiogram (...

September 26, 2014 — The American Association for Thoracic Surgery (AATS) has released new evidence-based guidelines for the prevention and treatment of perioperative and postoperative atrial...

AtriCure AtriClip Flex Atrial Fibrillation Therapies Cardiac Surgery LAA Occlude

AtriCure Inc. announced the introduction of the AtriClip Flex, a new device with a more flexible aluminum shaft that allows surgeons to better maneuver within a patient’s particular anatomy.

September 15, 2014 — A new gene-directed drug being tested through a research study called GENETIC-AF may improve care, quality of life and survival in patients with heart failure and atrial...

September 2, 2014 — Renal denervation reduces recurrent atrial fibrillation (AF) when performed with pulmonary vein isolation ablation in patients with AF and hypertension, according to research...

Janssen Research & Development, LLC and its development partner, Bayer HealthCare, announced results from the X-VeRT trial, demonstrating once-daily rivaroxaban may be an alternative...

topera, catheter, FIRMmap

John Muir Health's Concord medical center is the first hospital in Northern California and one of just 20 hospitals in the nation to begin treating patients who suffer from atrial fibrillation (...

August 22, 2014 — AliveCor announced the U.S. Food and Drug Administration (FDA) has granted the company clearance for its algorithm to detect atrial fibrillation (AF), the most common form of...

A clinical trial being conducted at Mission Health on a special catheter could one day help people with a persistent heart condition that does not respond to medication.

July 31, 2014 — Radiation therapy may offer a promising new noninvasive alternative treatment for the millions of Americans whose high blood pressure doesn’t respond to medication, suggests...

July 30, 2014 — St. Jude Medical announced CE mark approval and first use of the FlexAbility ablation catheter, a novel ablation technology used by electrophysiologists (EPs) for the treatment of...

A new physician poster presentation at the Atrial Fibrillation Symposium 19th Annual International Meeting in Orlando, Fla., reports long-term outcomes for the convergent procedure, a...

Medtronic Reveal XT ICM CRYSTAL AF Clinical Trial Atrial Fibrillation

Medtronic Inc. announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial Fibrillation) clinical trial, published in The New England Journal of Medicine. The trial found that...